Liver Cancer: October 2006 Archives

Test May Predict Liver Cancer Prognosis


FRIDAY, Oct. 13 (HealthDay News) -- Measuring levels of cells that originate in bone marrow could help doctors predict outcomes for liver cancer patients, researchers say.

Patients with inoperable heptocellular carcinoma (HCC) had higher levels of "endothelial progenitor cells" (EPCs) -- precursors to the endothelial cells that line blood vessels -- compared to patients with liver tumors that could be treated surgically.

About this Archive

This page is a archive of entries in the Liver Cancer category from October 2006.

Liver Cancer: November 2006 is the next archive.

Find recent content on the main index or look in the archives to find all content.